Although the study reported significantly longer PFS and ORR compared to single agent chemotherapy, results exhibited moderately significant drug related toxicity related to the addition of bevacizumab.
← all excerpts
Current Ovarian Cancer Maintenance Strategies and Promising New Developments.
1
—
—